Related Image: Bioethanol's impact on water supply 3 times higher than once thought |
...rchers at the McEwen Centre for Regenerative Medic...e ,SOS, distress signal that mobilizes specific he...ed heart after a heart attack. , While it has long...y to clear the dead tissue after a heart attack, w... important role of bone marrow adult stem cells in...
... drug that could help overcome HIV?fs growing resi...tested in combination with standard antivirals. Ca...i-HIV compounds called maturation inhibitors. The ... generally available for at least three years. , U...nt show resistance to one or more of their drugs, ...
...te research efforts to find modern factors that wo... and women, the gap is actually ancient and univer...rs. , "Women live longer in almost every country, ...ized since at least the mid-18th century," said Da...hool of Public Health and the Institute for Social...
Other Biology News:A surprise about our body clock 2A surprise about our body clock 3Trials for new drug to overcome HIV 2Evolutionary forces explain why women live longer than men 2(Date:11/20/2009)...R TOLEDO recently announced that Dr. Dominique Heb... of Process Analytical Technology (PAT) in Green C...1, 2009. , (PRWEB) Novemb...lytical Technology (PAT) in Green Chemistry and Gr...alytical Technology (PAT) case studies will be pre...
(Date:11/19/2009)...19 Dr. Mate Hidvegi, inventor of A...press release issued on November 17 by Biropharma ... false and self-serving statements about its U.S. ...i stated from his office in Budapest, Hungary: ,...does not apply to AveULTRA, www.aveultra.com , ...
(Date:11/19/2009)...WALTHAM, Mass., Nov. 19 Arlington ...d that the leading driver of antibiotic selection ...m activity against gram-positive and gram-negative...an cause nosocomial pneumonia, surveyed European p...ts that provide appropriate coverage against commo...
(Date:11/19/2009)...s Top Gene Synthesis Companies Form International ...t Practices in Risk Reduction ,Five Member Compa...sis Capacity , (PRWEB) No...ng gene synthesis companies today announced agreem...ol to promote biosecurity in the gene synthesis in...
Breaking Biology Technology:Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 4... Nov. 6 /PRNewswire-FirstCall/ - Dr. Brad Thompson...X: ONC, NASDAQ: ONCY), will present a,corporate ov... Annual,Healthcare Conference on Tuesday, November... at the New York Palace Hotel from November 10-12,...will be available at:, http://www.wsw.com/webcast/...
...ment to host call and webcast today at 5:00 p.m. E...recent business highlights -, SAN DIEGO, Calif., ...REX ), a biopharmaceutical company focused on,the ...tem-related,disorders, today announced unaudited f...ed September 30, 2008., Three Months Ended Septem...
...a., Nov. 6 ViroPharma Incorporated,(Nasdaq: VPHM...and chief,executive officer of ViroPharma, will pr...ment Conference at 12:25 P.M. ET on Wednesday, Nov...e New York Palace Hotel., ViroPharma also announc...fic officer of ViroPharma will present at the Laza...
Other Biology Technology:Media Advisory - Oncolytics Biotech Inc. to Present at Rodman & Renshaw 10th Annual Healthcare Conference 2Orexigen(R) Therapeutics Announces Third Quarter 2008 Financial Results 2Orexigen(R) Therapeutics Announces Third Quarter 2008 Financial Results 3Orexigen(R) Therapeutics Announces Third Quarter 2008 Financial Results 4Orexigen(R) Therapeutics Announces Third Quarter 2008 Financial Results 5Orexigen(R) Therapeutics Announces Third Quarter 2008 Financial Results 6Orexigen(R) Therapeutics Announces Third Quarter 2008 Financial Results 7Orexigen(R) Therapeutics Announces Third Quarter 2008 Financial Results 8Orexigen(R) Therapeutics Announces Third Quarter 2008 Financial Results 9ViroPharma to Present at Three November Healthcare Conferences 2Monkey sP-selectin ELISA Kit from Bender MedSystems
Monkey sE-selectin ELISA Kit from Bender MedSystems
BioBank -80nullC Automated sample library management system from Thermo Scientific
BioBank -80nullC Automated sample library management system with CO2 backup from Thermo Scientific
Biology Products: